FDA
approval
· 2018-02-01
FDA Approved: BUPRENORPHINE — Supplemental Application (Actavis Pharma, Inc.)
Summary
The FDA approved a supplemental application for buprenorphine from Actavis Pharma, Inc. under an approved ANDA, reflecting an added or updated aspect of the gen…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE (BUPRENORPHINE)